RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 134 filers reported holding RIGEL PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.49 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $178,000 | -18.7% | 49,600 | 0.0% | 0.00% | -100.0% |
Q2 2021 | $219,000 | +31.1% | 49,600 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $167,000 | -2.9% | 49,600 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $172,000 | +55.0% | 49,600 | 0.0% | 0.00% | – |
Q3 2020 | $111,000 | +19.4% | 49,600 | -2.7% | 0.00% | -100.0% |
Q3 2019 | $93,000 | -62.8% | 51,000 | -50.0% | 0.00% | 0.0% |
Q2 2019 | $250,000 | +20.8% | 102,000 | +63.2% | 0.00% | 0.0% |
Q1 2019 | $207,000 | +81.6% | 62,500 | +22.5% | 0.00% | 0.0% |
Q4 2018 | $114,000 | -44.9% | 51,000 | -18.4% | 0.00% | 0.0% |
Q3 2018 | $207,000 | +16.3% | 62,500 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $178,000 | -23.3% | 62,500 | 0.0% | 0.00% | -50.0% |
Q1 2018 | $232,000 | +146.8% | 62,500 | +35.9% | 0.00% | +100.0% |
Q1 2016 | $94,000 | -11.3% | 46,000 | -1.9% | 0.00% | 0.0% |
Q4 2014 | $106,000 | +6.0% | 46,900 | -8.8% | 0.00% | 0.0% |
Q3 2014 | $100,000 | -45.4% | 51,400 | +2.0% | 0.00% | -66.7% |
Q2 2014 | $183,000 | -13.3% | 50,400 | -7.4% | 0.00% | 0.0% |
Q1 2014 | $211,000 | +56.3% | 54,400 | +9.0% | 0.00% | +50.0% |
Q4 2013 | $135,000 | -22.9% | 49,900 | +2.0% | 0.00% | -33.3% |
Q3 2013 | $175,000 | – | 48,900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CM Management, LLC | 1,500,000 | $1,620,000 | 1.72% |
Soleus Capital Management, L.P. | 14,803,015 | $15,987,256 | 1.48% |
ARMISTICE CAPITAL, LLC | 17,136,000 | $18,506,880 | 0.28% |
SPHERA FUNDS MANAGEMENT LTD. | 1,228,126 | $1,326,376 | 0.24% |
GSA CAPITAL PARTNERS LLP | 971,441 | $1,049 | 0.09% |
NJ State Employees Deferred Compensation Plan | 200,000 | $216,000 | 0.03% |
Providence Wealth Advisors, LLC | 27,500 | $29,013 | 0.03% |
XTX Topco Ltd | 164,238 | $177,377 | 0.03% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 3,369,076 | $3,638,602 | 0.02% |
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 1,151,765 | $1,243,906 | 0.02% |